Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta

American Journal of Obstetrics and Gynecology

Volumn 206, Issue 3, 2012, Pages 253.e10-253.e15

  Cudmore, Melissa J ^a   Ramma, Wenda ^a   Cai, Meng ^a   Fujisawa, Takeshi ^a   Ahmad, Shakil ^a   Al Ani, Bahjat ^b   Ahmed, Asif ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

endothelial cells; heme oxygenase1; placenta; resveratrol; soluble fms like tyrosine kinase1

Indexed keywords

CELL PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; HEME OXYGENASE 1; RESVERATROL; VASCULOTROPIN RECEPTOR 1;

ANTIINFLAMMATORY ACTIVITY; CELL PROTECTION; CELL TRANSFORMATION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DRUG EFFECT; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; EXPLANT; FEMALE; GENE EXPRESSION; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEOTROPHOBLAST CELL; PLACENTA; PLACENTA EXPLANT; PREECLAMPSIA; PRIORITY JOURNAL; TROPHOBLAST; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; WESTERN BLOTTING;

EID: 84857792906     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.11.010     Document Type: Conference Paper

References (38)

1. S. Ahmad, A. Ahmed Regulation of soluble VEGFR-1 by VEGF and oxygen and its elevation in pre-eclampsia and fetal growth restriction Placenta 22 2001 A7
2. P. Vuorela, S. Helske, C. Hornig, K. Alitalo, H. Weich, E. Halmesmki Amniotic fluidsoluble vascular endothelial growth factor receptor1 in preeclampsia Obstet Gynecol 95 2000 353 357
3. S.E. Maynard, J.Y. Min, J. Merchan Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
4. S. Ahmad, A. Ahmed Elevated placental soluble vascular endothelial growth factor receptor1 inhibits angiogenesis in preeclampsia Circ Res 95 2004 884 891
5. A. Bergmann, S. Ahmad, M. Cudmore Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model J Cell Mol Med 14 2010 1857 1867
6. R. Thadhani, T. Kisner, H. Hagmann Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia Circulation 124 2011 940 950
7. L.E. Otterbein, J.K. Kolls, L.L. Mantell, J.L. Cook, J. Alam, A.M. Choi Exogenous administration of heme oxygenase1 by gene transfer provides protection against hyperoxia-induced lung injury J Clin Invest 103 1999 1047 1054
8. J. Dulak, J. Deshane, A. Jozkowicz, A. Agarwal Heme oxygenase1 and carbon monoxide in vascular pathobiology: focus on angiogenesis Circulation 117 2008 231 241
9. A. Ahmed, M. Rahman, X. Zhang Induction of placental heme oxygenase1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation Mol Med 6 2000 391 409
10. M. Cudmore, S. Ahmad, B. Al-Ani Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase1 Circulation 115 2007 1789 1797
11. Y.P. Wang, Y.H. Yu Expression of endogenous heme oxygenase on surface of placental trophoblasts of pregnant women with intrauterine growth retardation of the fetus Di Yi Jun Yi Da Xue Xue Bao 22 2002 637 639
12. G.E. Lash, B.E. Mclaughlin, S.K. MacDonald Relationship between tissue damage and heme oxygenase expression in chorionic villi of term human placenta Am J Physiol Heart Circ Physiol 284 2003 H160 H167
13. A.C. Zenclussen, E. Lim, S. Knoeller Heme oxygenases in pregnancy II: HO-2 is down-regulated in human pathologic pregnancies Am J Reprod Immunol 50 2003 66 76
14. M. Nakamura, A. Sekizawa, Y. Purwosunu Cellular mRNA expressions of anti-oxidant factors in the blood of preeclamptic women Prenat Diagn 29 2009 691 696
15. A. Farina, A. Sekizawa, P. De Sanctis Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia Prenat Diagn 28 2008 956 961
16. E.N. Frankel, A.L. Waterhouse, J.E. Kinsella Inhibition of human LDL oxidation by resveratrol Lancet 341 1993 1103 1104
17. A.A. Bertelli, L. Giovannini, D. Giannessi Antiplatelet activity of synthetic and natural resveratrol in red wine Int J Tissue React 17 1995 1 3
18. A. Di Santo, A. Mezzetti, E. Napoleone Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells J Thromb Haemost 1 2003 1089 1095
19. U.R. Pendurthi, L.V. Rao Resveratrol suppresses agonist-induced monocyte adhesion to cultured human endothelial cells Thromb Res 106 2002 243 248
20. M. Kampa, A. Hatzoglou, G. Notas Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines Nutr Cancer 37 2000 223 233
21. T. Wallerath, G. Deckert, T. Ternes Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase Circulation 106 2002 1652 1658
22. A. Sgambato, R. Ardito, B. Faraglia, A. Boninsegna, F.I. Wolf, A. Cittadini Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage Mutat Res 496 2001 171 180
23. C.Y. Chen, J.H. Jang, M.H. Li, Y.J. Surh Resveratrol up-regulates heme oxygenase1 expression via activation of NF-E2-related factor 2 in PC12 cells Biochem Biophys Res Commun 331 2005 993 1000
24. S.H. Juan, T.H. Cheng, H.C. Lin, Y.L. Chu, W.S. Lee Mechanism of concentration-dependent induction of heme oxygenase1 by resveratrol in human aortic smooth muscle cells Biochem Pharmacol 69 2005 41 48
25. S. Das, C.G. Fraga, D.K. Das Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB Free Radic Res 40 2006 1066 1075
26. J.A. Baur, D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493 506
27. M. Athar, J.H. Back, X. Tang Resveratrol: a review of preclinical studies for human cancer prevention Toxicol Appl Pharmacol 224 2007 274 283
28. D.J. Boocock, G.E. Faust, K.R. Patel Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent Cancer Epidemiol Biomarkers Prev 16 2007 1246 1252
29. L.D. Williams, G.A. Burdock, J.A. Edwards, M. Beck, J. Bausch Safety studies conducted on high-purity trans-resveratrol in experimental animals Food Chem Toxicol 47 2009 2170 2182
30. J.Y. Jang, D. Park, S. Shin Antiteratogenic effect of resveratrol in mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin Eur J Pharmacol 591 2008 280 283
31. N.P. Singh, U.S. Singh, M. Nagarkatti, P.S. Nagarkatti Resveratrol (3,5,4′-trihydroxystilbene) protects pregnant mother and fetus from the immunotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin Mol Nutr Food Res 55 2011 209 219
32. C.K. Singh, A. Kumar, D.B. Hitchcock Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam Mol Nutr Food Res 55 2011 1186 1196
33. S. Ahmad, P.W. Hewett, P. Wang Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxidemediated angiogenesis Circ Res 99 2006 715 722
34. G. Smith, R.S. Dawe, C. Clark Quantitative real-time reverse transcription-polymerase chain reaction analysis of drug metabolizing and cytoprotective genes in psoriasis and regulation by ultraviolet radiation J Invest Dermatol 121 2003 390 398
35. K. Morishita, D.E. Johnson, L.T. Williams A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression J Biol Chem 270 1995 27948 27953
36. L. Bellamy, J.P. Casas, A.D. Hingorani, D.J. Williams Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis BMJ 335 2007 974
37. A. Amri, J.C. Chaumeil, S. Sfar, C. Charrueau Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release 2011 Sep 25 [Epub ahead of print]
38. E. Beinder, M.G. Mohaupt, D. Schlembach Nitric oxide synthase activity and Doppler parameters in the fetoplacental and uteroplacental circulation in preeclampsia Hypertens Pregnancy 18 1999 115 127